Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test

被引：2
|
作者：
Ishido, Shun [1 ]
Tamaki, Nobuharu [1 ]
Inada, Kento [1 ]
Itakura, Jun [1 ]
Takahashi, Yuka [1 ]
Uchihara, Naoki [1 ]
Suzuki, Keito [1 ]
Tanaka, Yuki [1 ]
Miyamoto, Haruka [1 ]
Yamada, Michiko [1 ]
Matsumoto, Hiroaki [1 ]
Nobusawa, Tsubasa [1 ]
Keitoku, Taisei [1 ]
Takaura, Kenta [1 ]
Tanaka, Shohei [1 ]
Maeyashiki, Chiaki [1 ]
Yasui, Yutaka [1 ]
Tsuchiya, Kaoru [1 ]
Nakanishi, Hiroyuki [1 ]
Kurosaki, Masayuki [1 ,2 ]
Izumi, Namiki [1 ]
机构：
[1] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
[2] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, 1-26-1 Kyonan Cho, Musashino, Tokyo 1808610, Japan
来源：
CLINICAL CASE REPORTS | 2023年 / 11卷 / 07期
关键词：
comprehensive genomic profiling; fibroblast growth factor receptor 2; intrahepatic cholangiocarcinoma; pemigatinib; PHASE-II; MULTICENTER; GEMCITABINE; CISPLATIN; S-1;
D O I：
10.1002/ccr3.7664
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Key Clinical MessageThe liquid CGP was useful for detecting FGFR2 fusion and the patient experienced typical side effects (nail disorders, hyperphosphatemia, and taste disorders) of pemigatinib that required treatment.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Pemigatinib in cholangiocarcinoma with a FGFR2 rearrangement or fusion
    Storandt, Michael H.
    Jin, Zhaohui
    Mahipal, Amit
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (12) : 1265 - 1274
  • [2] Intrahepatic cholangiocarcinoma with FGFR2 fusion gene positive that responded to pemigatinib and caused hypophosphatemia
    Yoshinori Kikuchi
    Kazuhisa Yamaguchi
    Ryo Shimizu
    Yuu Matsumoto
    Yasuko Kurose
    Naoki Okano
    Yuichirou Otsuka
    Kazutoshi Shibuya
    Takahisa Matsuda
    Hideaki Shimada
    International Cancer Conference Journal, 2023, 12 : 285 - 290
  • [3] Intrahepatic cholangiocarcinoma with FGFR2 fusion gene positive that responded to pemigatinib and caused hypophosphatemia
    Kikuchi, Yoshinori
    Yamaguchi, Kazuhisa
    Shimizu, Ryo
    Matsumoto, Yuu
    Kurose, Yasuko
    Okano, Naoki
    Otsuka, Yuichirou
    Shibuya, Kazutoshi
    Matsuda, Takahisa
    Shimada, Hideaki
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2023, 12 (04) : 285 - 290
  • [4] FGFR2 fusion and/or rearrangement profiling in Chinese patients with intrahepatic cholangiocarcinoma
    Huang, X-W.
    Shi, G-M.
    Zhang, T.
    Bao, L-Q.
    Wen, T-F.
    Zhang, B.
    Peng, T.
    Zhao, H.
    Kuang, M.
    Wang, W-L.
    Ran, J-H.
    Liu, Y-B.
    Gong, W.
    Mou, H-B.
    Luo, Y.
    Wang, Y.
    Sun, H.
    Fan, J.
    Liu, L-X.
    Dai, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S379 - S379
  • [5] Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling
    Silverman, Ian M.
    Li, Meijuan
    Murugesan, Karthikeyan
    Krook, Melanie A.
    Javle, Milind M.
    Kelley, Robin K.
    Borad, Mitesh J.
    Roychowdhury, Sameek
    Meng, Wei
    Yilmazel, Bahar
    Milbury, Coren
    Shewale, Shantanu
    Feliz, Luis
    Burn, Timothy C.
    Albacker, Lee A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (04): : 351 - 364
  • [6] New European approvals: Pemigatinib - cholangiocarcinoma with a FGFR2 fusion or rearrangement
    Delaye, Matthieu
    Pernot, Simon
    BULLETIN DU CANCER, 2021, 108 (05) : 446 - 447
  • [7] FGFR2 fusion in resectable intrahepatic cholangiocarcinoma patients
    Xu, S.
    Zheng, Y.
    Gong, W.
    Li, B.
    Wang, Y.
    Li, H.
    Zhao, S.
    Shi, X.
    Zhang, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S267 - S267
  • [8] Postpartum related intrahepatic cholangiocarcinoma with FGFR2 fusion and severe hyperbilirubinemia with response to FGFR inhibitor pemigatinib: case report and review
    Washburn, Leslie
    Mahipal, Amit
    Jatoi, Aminah
    Kottschade, Lisa
    Tran, Nguyen
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (06) : 2627 - 2636
  • [9] Cholangiocarcinoma: fusions in FGFR2 detected in liquid biopsy
    Patriarca, M. E.
    Coma, M. I.
    Naranjo Hans, D.
    Fernandez Rodriguez, M. C.
    Bellosillo, B.
    Visa Turmo, L.
    Lloveras, B.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S245 - S246
  • [10] Neoadjuvant pemigatinib as a bridge to living donor liver transplantation for intrahepatic cholangiocarcinoma with FGFR2 gene rearrangement
    Byrne, Matthew M.
    Dunne, Richard F.
    Melaragno, Jennifer I.
    Chavez-Villa, Mariana
    Hezel, Aram
    Liao, Xiaoyan
    Ertreo, Marco
    Al-Judaibi, Bandar
    Orloff, Mark
    Hernandez-Alejandro, Roberto
    Tomiyama, Koji
    AMERICAN JOURNAL OF TRANSPLANTATION, 2025, 25 (03) : 623 - 627
12345